Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(27%)

Phase Distribution

Ph not_applicable
9
82%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
N/ANon-phased studies
9(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(4)
Terminated(4)
Other(3)

Detailed Status

Completed4
Terminated3
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
57.1%
Most Advanced
N/A

Trials by Phase

N/A9 (100.0%)

Trials by Status

withdrawn19%
terminated327%
unknown327%
completed436%

Recent Activity

0 active trials
Showing 5 of 11
completednot_applicable

Sonographic Evaluation of Diaphragmatic Function Under Nasal High-flow (NHF) and Non-invasive Ventilation (NIV) in Respiratory Insufficiency

NCT07050147
completednot_applicable

Nasal High Flow Therapy in Surgical Patients with Unrecognized Obstructive Sleep Apnea

NCT03964376
unknownnot_applicable

Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom

NCT05167201
terminatednot_applicable

Nasal High Flow to Maintain the Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

NCT03882372
unknown

ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

NCT05036161
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07050147Not Applicable

Sonographic Evaluation of Diaphragmatic Function Under Nasal High-flow (NHF) and Non-invasive Ventilation (NIV) in Respiratory Insufficiency

Completed
NCT03964376Not Applicable

Nasal High Flow Therapy in Surgical Patients with Unrecognized Obstructive Sleep Apnea

Completed
NCT05167201Not Applicable

Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom

Unknown
NCT03882372Not Applicable

Nasal High Flow to Maintain the Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

Terminated
NCT05036161

ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

Unknown
NCT03466385Not Applicable

NHF vs NIV in Patients With Acute Exacerbation of COPD

Unknown
NCT02632825Not Applicable

Effects of Nasal High Flow Therapy on Ventilation and Gas Exchange in Healthy Newborns

Completed
NCT02058810Not Applicable

Nasal High Flow at Acute Hart Failure

Terminated
NCT03214458Not Applicable

Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02547688Not Applicable

Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep

Withdrawn
NCT02230020

Efficacy of High Flow Therapy in COPD At Home

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11